Revenue decreased by 4.9% to $527,478 for the three months ended September 30, 2024 compared to revenue for the three months ended September 30, 2023. Elevai’s Chief Executive Officer and
Revenue decreased by 4.9% to $527,478 for the three months ended September 30, 2024 compared to revenue for the three months ended September 30, 2023. Elevai’s Chief Executive Officer and
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Verrica Pharmaceuticals (VRCA), 658% surge in interest Macrogenics (MGNX),
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Verrica Pharmaceuticals (VRCA), 618% surge in interest Verona Pharma
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Iterum Therapeutics (ITRM), 1,042% surge in interest Elevai Labs
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Genprex (GNPX), 4,021% surge in interest Aptevo Therapeutics (APVO),